PARP7 as a new target for activating anti-tumor immunity in cancer

ADP-ribosyl transferases (ARTs) are a family of enzymes which catalyze the addition of a chain (PARylation) or a single moiety (MARylation) of ADP-ribose to their substrates. PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative...

Full description

Saved in:
Bibliographic Details
Main Authors: Popova, Katerina (Author) , Benedum, Johannes (Author) , Engl, Magdalena (Author) , Lütgendorf-Caucig, Carola (Author) , Fossati, Piero (Author) , Widder, Joachim (Author) , Podar, Klaus (Author) , Slade, Dea (Author)
Format: Article (Journal)
Language:English
Published: May 2025
In: EMBO molecular medicine
Year: 2025, Volume: 17, Issue: 5, Pages: 872-888
ISSN:1757-4684
DOI:10.1038/s44321-025-00214-6
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s44321-025-00214-6
Verlag, kostenfrei, Volltext: https://www.embopress.org/doi/full/10.1038/s44321-025-00214-6
Get full text
Author Notes:Katerina Popova, Johannes Benedum, Magdalena Engl, Carola Lütgendorf-Caucig, Piero Fossati, Joachim Widder, Klaus Podar & Dea Slade

MARC

LEADER 00000caa a2200000 c 4500
001 1937765997
003 DE-627
005 20251020155804.0
007 cr uuu---uuuuu
008 251006s2025 xx |||||o 00| ||eng c
024 7 |a 10.1038/s44321-025-00214-6  |2 doi 
035 |a (DE-627)1937765997 
035 |a (DE-599)KXP1937765997 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Popova, Katerina  |e VerfasserIn  |0 (DE-588)1378279549  |0 (DE-627)1937768252  |4 aut 
245 1 0 |a PARP7 as a new target for activating anti-tumor immunity in cancer  |c Katerina Popova, Johannes Benedum, Magdalena Engl, Carola Lütgendorf-Caucig, Piero Fossati, Joachim Widder, Klaus Podar & Dea Slade 
246 3 3 |a PARP seven as a new target for activating anti-tumor immunity in cancer 
264 1 |c May 2025 
300 |b Illustrationen 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 24. März 2025 
500 |a Gesehen am 10.06.2025 
520 |a ADP-ribosyl transferases (ARTs) are a family of enzymes which catalyze the addition of a chain (PARylation) or a single moiety (MARylation) of ADP-ribose to their substrates. PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative regulator of the type I interferon (IFN-I) and nuclear receptor signaling, and due to its aberrant expression in cancer, contributing to disease progression and immune evasion. PARP7-mediated ADP-ribosylation can differentially affect protein stability. On the one hand, PARP7-mediated ADP-ribosylation of the transcription factor FRA1 protects it from proteosomal degradation and thereby supports its function in negatively regulating IRF1 and the expression of apoptosis and immune signaling genes. On the other hand, PARP7-mediated ADP-ribosylation of aryl hydrocarbon receptor (AHR) and estrogen receptor (ER) marks them for proteosomal degradation. PARP7 also ADP-ribosylates the ligand-bound androgen receptor (AR), which is recognized by DTX3L-PARP9 that modulate the AR transcriptional activity. In this review, we discuss PARP7 enzymatic properties, biological functions and known substrates, its role in various cancers, and its targeting by specific inhibitors. 
650 4 |a ADP-ribosylation 
650 4 |a Anti-tumor Immunity 
650 4 |a Nuclear Receptors 
650 4 |a PARP7 
650 4 |a Type I Interferon Response 
700 1 |a Benedum, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Engl, Magdalena  |e VerfasserIn  |4 aut 
700 1 |a Lütgendorf-Caucig, Carola  |e VerfasserIn  |0 (DE-588)1368418694  |0 (DE-627)1927981859  |4 aut 
700 1 |a Fossati, Piero  |e VerfasserIn  |4 aut 
700 1 |a Widder, Joachim  |e VerfasserIn  |4 aut 
700 1 |a Podar, Klaus  |e VerfasserIn  |0 (DE-588)1058672169  |0 (DE-627)797396594  |0 (DE-576)414826795  |4 aut 
700 1 |a Slade, Dea  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |a European Molecular Biology Organization  |t EMBO molecular medicine  |d [London] : Nature Publishing Group UK, 2009  |g 17(2025), 5 vom: Mai, Seite 872-888  |h Online-Ressource  |w (DE-627)594772761  |w (DE-600)2485479-7  |w (DE-576)305355961  |x 1757-4684  |7 nnas 
773 1 8 |g volume:17  |g year:2025  |g number:5  |g month:05  |g pages:872-888  |g extent:17  |a PARP7 as a new target for activating anti-tumor immunity in cancer 
856 4 0 |u https://doi.org/10.1038/s44321-025-00214-6  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.embopress.org/doi/full/10.1038/s44321-025-00214-6  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251006 
993 |a Article 
994 |a 2025 
998 |g 1368418694  |a Lütgendorf-Caucig, Carola  |m 1368418694:Lütgendorf-Caucig, Carola  |d 910000  |d 911400  |e 910000PL1368418694  |e 911400PL1368418694  |k 0/910000/  |k 1/910000/911400/  |p 4 
999 |a KXP-PPN1937765997  |e 4781247210 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Katerina Popova, Johannes Benedum, Magdalena Engl, Carola Lütgendorf-Caucig, Piero Fossati, Joachim Widder, Klaus Podar & Dea Slade"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"May 2025"}],"id":{"doi":["10.1038/s44321-025-00214-6"],"eki":["1937765997"]},"physDesc":[{"noteIll":"Illustrationen","extent":"17 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["European Molecular Biology Organization (EMBO)"]},"id":{"zdb":["2485479-7"],"doi":["10.1002/(ISSN)1757-4684"],"eki":["594772761"],"issn":["1757-4684"]},"origin":[{"publisherPlace":"[London] ; Heidelberg ; Weinheim","publisher":"Nature Publishing Group UK ; EMBO Press ; Wiley-VCH","dateIssuedDisp":"[2009]-"}],"language":["eng"],"corporate":[{"role":"aut","display":"European Molecular Biology Organization","roleDisplay":"VerfasserIn"}],"recId":"594772761","disp":"European Molecular Biology OrganizationEMBO molecular medicine","note":["Gesehen am 5. November 2022","Fortsetzung der Druck-Ausgabe"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"5","pages":"872-888","year":"2025","extent":"17","volume":"17","text":"17(2025), 5 vom: Mai, Seite 872-888"},"pubHistory":["Vol. 1, No. 1 (Apr 1, 2009)-"],"title":[{"title":"EMBO molecular medicine","title_sort":"EMBO molecular medicine"}]}],"person":[{"family":"Popova","given":"Katerina","roleDisplay":"VerfasserIn","display":"Popova, Katerina","role":"aut"},{"role":"aut","display":"Benedum, Johannes","roleDisplay":"VerfasserIn","given":"Johannes","family":"Benedum"},{"roleDisplay":"VerfasserIn","display":"Engl, Magdalena","role":"aut","family":"Engl","given":"Magdalena"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Lütgendorf-Caucig, Carola","given":"Carola","family":"Lütgendorf-Caucig"},{"family":"Fossati","given":"Piero","roleDisplay":"VerfasserIn","display":"Fossati, Piero","role":"aut"},{"given":"Joachim","family":"Widder","role":"aut","display":"Widder, Joachim","roleDisplay":"VerfasserIn"},{"family":"Podar","given":"Klaus","roleDisplay":"VerfasserIn","display":"Podar, Klaus","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Slade, Dea","given":"Dea","family":"Slade"}],"title":[{"title_sort":"PARP7 as a new target for activating anti-tumor immunity in cancer","title":"PARP7 as a new target for activating anti-tumor immunity in cancer"}],"note":["Veröffentlicht: 24. März 2025","Gesehen am 10.06.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1937765997","language":["eng"],"titleAlt":[{"title":"PARP seven as a new target for activating anti-tumor immunity in cancer"}]} 
SRT |a POPOVAKATEPARP7ASANE2025